Inventor · disambiguated record
Stephen E. Mercer
Also filed as: MERCER STEPHEN E
14 granted patents·3 pending applications·55 citations·filing 2001–2021
89Inventor score
Top patents by PatentIndex Score
17 records- 0191US7384930B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 10, 2008·21 cites·13 claims
- 0290US7384931B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 10, 2008·10 cites·6 claims
- 0387US10799523B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Oct 13, 2020·3 cites·8 claims
- 0486US7772244B2Therapeutic agents for the treatment of migraineBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 10, 2010·12 cites·14 claims
- 0585US11866430B2Naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 9, 2024·3 cites·11 claims
- 0671US7470680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·9 claims
- 0770US2022143064A1Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0866US11058767B2CAMK2D antisense oligonucleotides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 13, 2021·0 cites·17 claims
- 0963US7125870B2Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzymeBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 24, 2006·2 cites·28 claims
- 1062US11077132B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Aug 3, 2021·0 cites·13 claims
- 1159US6620823B2Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB PHARME CO·Filed 2001·Granted Sep 16, 2003·3 cites·18 claims
- 1258US7544680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 9, 2009·0 cites·9 claims
- 1357US2021378652A1Camk2d antisense oligonucleotides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1453US2022213484A1Angptl2 antisense oligonucleotides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1551US7470679B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·0 cites·10 claims
- 1643US11761951B2Methods of selecting therapeutic moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 19, 2023·0 cites·19 claims
- 1740US9833454B2Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 5, 2017·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Stephen E. Mercer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →